The estimated Net Worth of Arash Ghadar Ghadr is at least $3 Thousand dollars as of 5 January 2024. Arash Ghadr owns over 100,000 units of Nemaura Medical Inc stock worth over $3,000 and over the last few years Arash sold NMRD stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Arash Ghadr NMRD stock SEC Form 4 insiders trading
Arash has made over 1 trades of the Nemaura Medical Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Arash bought 100,000 units of NMRD stock worth $14,000 on 5 January 2024.
The largest trade Arash's ever made was buying 100,000 units of Nemaura Medical Inc stock on 5 January 2024 worth over $14,000. On average, Arash trades about 100,000 units every 0 days since 2024. As of 5 January 2024 Arash still owns at least 100,000 units of Nemaura Medical Inc stock.
You can see the complete history of Arash Ghadr stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Arash Ghadr's mailing address?
Arash's mailing address filed with the SEC is C/O NEMAURA MEDICAL, INC., 57 WEST 57TH STREET, NEW YORK, NY, 10019.
Insiders trading at Nemaura Medical Inc
Over the last 7 years, insiders at Nemaura Medical Inc have traded over $0 worth of Nemaura Medical Inc stock and bought 100,000 units worth $14,000 . The most active insiders traders include Arash Ghadar Ghadr. On average, Nemaura Medical Inc executives and independent directors trade stock every 0 days with the average trade being worth of $3,000. The most recent stock trade was executed by Arash Ghadar Ghadr on 5 January 2024, trading 100,000 units of NMRD stock currently worth $14,000.
What does Nemaura Medical Inc do?
nemaura medical inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. the company provides sugarbeat, a non-invasive continuous glucose monitoring device for use by persons with type i and type ii diabetes, as well as for screening pre-diabetic patients. it has a license agreement with healthimation, llc, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for type 2 diabetes, prediabetes, and general wellness; the why wait app; and common law trademarks which incorporate the mark why wait or whywait and the use of licensed marks. nemaura medical inc. was founded in 2009 and is based in new york, new york.
What does Nemaura Medical Inc's logo look like?
Complete history of Arash Ghadr stock trades at Nemaura Medical Inc
Nemaura Medical Inc executives and stock owners
Nemaura Medical Inc executives and other stock owners filed with the SEC include:
-
Justin James Mclarney,
Chief Fin. Officer -
Dr. Dewan Fazlul Hoque Chowdhury Ph.D.,
Chairman, CEO & Pres -
Dewan Chowdhury,
Chairman of the Board, President, Chief Executive Officer -
Salim Natha,
Independent Director -
Thomas Moore,
Independent Director -
Timothy Johnson,
Independent Director -
Bashir Timol,
Director, Chief Business Officer -
Chris Avery,
Vice President - Global Business Operations -
Justin Mclarney,
Chief Financial Officer -
Samantha Sanders,
Global Head of Digital Programs -
Thomas Bendix Mortensen,
Head of E.U. Commercial Operations & Marketing -
Jay L. Warner,
Head of U.S. Commercial Operations -
Dr. Fred Schaebsdau M.D., Ph.D.,
Pres of Strategy & Strategic Alliances -
Sufyan Ismail,
10% owner